Skip to content

SENIOR FOCUSED PRIMARY CARE SYSTEMS

Proactive Dementia Detection, Built for Senior Care 

Detect dementia earlier, align with value-based care goals, and reduce unnecessary specialist referrals—without adding burden to your team.

Request a Demo   See How It Works

Fast, Scalable Screening. No Specialist Required

In primary care you don’t need more tools–you need the right ones. Creyos gives you a screening solution for cognitive impairment that’s easy to administer and delivers instant, accurate, results.

Screening-3

Results in under 10 minutes

Fits seamlessly into AWVs with results accessible from EMRs like Epic, athenahealth, AdvancedMD and more. No workflow disruption or added appointment time.

Improves detection accuracy

Scientifically validated digital tasks with 100% sensitivity and 86% specificity1 help PCPs catch early cognitive decline and improve dementia capture.

Aligned to DSM-5 criteria

Directly mapped to DSM-5 criteria, blending objective cognitive measures with patient-reported insights for actionable results and care decisions. 

Catch What Standard Screeners Might Miss 

Traditional screeners can overlook the early, subtle signs of cognitive and behavioral decline. Creyos is built to catch what others miss—using brief, validated tasks to assess key cognitive domains and compare performance to one of the largest normative datasets available. Embedded behavioral health questionnaires add another layer of insight. The result: greater sensitivity, earlier detection, and more confident decisions.

See How Creyos Compares

Creyos Early Detection-3

Document with Precision. Capture the Right Codes

Accurate dementia detection is critical under CMS-HCC V28. Creyos equips your team with a standardized, digital, patient-friendly assessment that boosts screening completion rates by up to 10%2 and can improve capture rates by 5%-10%3, so RAF scores fully reflect each patient’s complexity, costs, and care needs.

Learn More

Precision-3

Decades of Science. Hundreds of Studies. Millions of Assessments. One Trusted Platform.

 Learn About The Science

Science-Sep-15-2025-03-38-09-9993-PM
Justin-Hunt-MD-ABHIN-Oakstreet

"We really wanted to help our Oak Street primary care providers understand the exact diagnostic criteria for dementia and then tying those DSM-5 criteria to the different aspects of the tool. Creyos has been a perfect fit for us in many ways because it has the objective impairment measures with the screener and the assessment, but then also importantly there's a questionnaire on functional decline which is required for DSM-5. That structure was an attractive point for us."

Justin Hunt, MD, MS
Senior Medical Director, Behavioral Health
Oak Street Health

Request a Demo

Reduce Unnecessary Referrals. Prioritize the Right Patients. 

Not every cognitive concern needs a referral. With Creyos, PCPs can properly stage impairment, keep more care in-house, and triage more effectively. That means less strain on specialists, faster access for those who truly need it, and stronger continuity of care.

Key Benefits:

  • Preserve specialist access for complex cases
  • Reduce patient wait times and delays
  • Enable early intervention in primary care
  • Avoid unnecessary cost increases
workflow-Aug-25-2025-04-10-26-6368-PM

Turn Cognitive Data Into Actionable Care Plans 

Don’t just flag cognitive concerns–provide guidance on what to do next. Creyos’s built-in care planning tools help your team translate assessment results into personalized next steps for their patients, from lifestyle support, to medication management, to caregiver instructions. Plus, longitudinal tracking makes it easy to monitor change over time and engage patients and families in earlier, more informed conversations that support aging in place.  

Careplan-2

Built to Support High-Risk Panels at Scale

Whether managing thousands of Medicare Advantage lives or operating in dozens of markets, Creyos scales with you. Custom reports and analytics support allow you to track cognitive screening completion across panels, identify gaps, and get population-level insights to improve your cognitive care strategies.

Platform Highlights:

  • Centralized tracking across locations
  • Integrates with care management workflows
  • Ongoing data analytics support
Scale-Aug-25-2025-06-37-59-2049-PM

Security You Can Trust

Protecting patient data isn’t optional, it’s essential. That’s why Creyos is both SOC 2 and HIPAA compliant. You can be confident that every interaction meets the strictest security and privacy standards.

Enterprise Grade Reliability

Your organization can’t afford downtime. Our enterprise-grade infrastructure is engineered for speed, resilience, and scalability so you can deliver consistent, uninterrupted care no matter how large you grow.

A Partner, Not a Vendor 

From on-site onboarding and integration to personalized training and ongoing guidance, our experts partner with you to customize workflows and ensure lasting success—not just at go-live, but every day after.

Bring High Quality Cognitive Care to the Front Lines of Primary Care 

Detect dementia earlier, reduce downstream costs, and deliver the proactive, person-centered care your model is built on with Creyos.

Request a Demo

Frequently asked questions

Can Creyos cognitive assessments be administered remotely?

Yes, all cognitive assessments from Creyos can be administered remotely or in-clinic.

Can I use Creyos to track cognitive decline over time?

Yes, Creyos cognitive assessments are designed to effectively track cognitive decline over time. Assessments not only allow for retesting, but reports also automatically compare current and past results to readily highlight patient progression. 

Is Creyos a HIPAA-compliant brain health assessment platform?

Yes, Creyos is fully HIPAA-compliant.

1. Urian, Diana & Gupta, Garima & Battista, Mike & Wild, Conor & Owen, Adrian. (2025). Early Cognitive Screening for Individuals on the Alzheimer’s Disease Continuum. https://doi.org/10.31234/osf.io/e7hpu_v1  
2. Based on observed performance in senior-focused primary care groups using Creyos. Actual improvements vary depending on population demographics, care workflows, and organizational practices. 
3. Capture rate improvements based on average performance across practices adopting digital cognitive assessment. Results depend on patient populations, clinical judgment, and existing screening workflows.

Important Information:

Creyos provides a scientifically-validated and objective measure of an individual’s cognition. It should be used in conjunction with other information and clinical judgments to reach conclusions regarding and individual's health. It is not a stand-alone diagnostic tool and cannot replace the judgement of a healthcare professional. Creyos does not assume responsibility for the outcome of decisions made based on Creyos data.